Universe Pharmaceuticals (UPC) Equity Average: 2020-2024
Historic Equity Average for Universe Pharmaceuticals (UPC) over the last 5 years, with Sep 2024 value amounting to $36.7 million.
- Universe Pharmaceuticals' Equity Average fell 0.42% to $37.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $37.4 million, marking a year-over-year decrease of 0.42%. This contributed to the annual value of $36.7 million for FY2024, which is 16.07% up from last year.
- As of FY2024, Universe Pharmaceuticals' Equity Average stood at $36.7 million, which was up 16.07% from $31.7 million recorded in FY2023.
- In the past 5 years, Universe Pharmaceuticals' Equity Average registered a high of $41.2 million during FY2022, and its lowest value of $16.6 million during FY2020.
- Its 3-year average for Equity Average is $36.5 million, with a median of $36.7 million in 2024.
- Per our database at Business Quant, Universe Pharmaceuticals' Equity Average skyrocketed by 104.28% in 2021 and then decreased by 23.11% in 2023.
- Universe Pharmaceuticals' Equity Average (Yearly) stood at $16.6 million in 2020, then skyrocketed by 104.28% to $33.9 million in 2021, then increased by 21.43% to $41.2 million in 2022, then fell by 23.11% to $31.7 million in 2023, then climbed by 16.07% to $36.7 million in 2024.